CLINICAL_TRIALS ClinicalTrials.gov record update

The De-novo Use of Eculizumab Alongside Conventional Therapy in Presensitized Patients Receiving Cardiac Transplantation: An Open-Label, Investigator-Initiated Pilot Trial: [The DUET Cardiac Trial]

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02013037
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:11.644637+00:00
Published At: 2021-05-03T00:00:00+00:00
Record Updated At: 2021-05-03
Results Posted At: 2021-05-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Antibody-mediated Rejection", "Hyperacute Rejection of Cardiac Transplant", "Left Ventricular Dysfunction", "Cardiac Allograft Vasculopathy", "Heart Graft Dysfunction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-05-03"
protocolSection.identificationModule.nctId: "NCT02013037"
protocolSection.identificationModule.officialTitle: "The De-novo Use of Eculizumab Alongside Conventional Therapy in Presensitized Patients Receiving Cardiac Transplantation: An Open-Label, Investigator-Initiated Pilot Trial: [The DUET Cardiac Trial]"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-05-03"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.